Zoledronate Generic 3mg/15ml Concentrate Vial from Japan
Concentrated zoledronic acid salt solution 3mg in 15ml vial requiring dilution for tumor-induced hypercalcemia treatment, supplied in single-dose glass packaging. Classified under HTS 3004.90.92.75 for its specific zoledronic acid salt content in measured therapeutic doses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Submit import drug alert notice 72 hours prior via FDA PREDICT system; ensure vial labeling includes 'dilute before use' and osmolarity warnings; test for leachables from glass primary packaging